Description
Regulatory description in preparation. This entry is part of the enriched CosIng dataset published by BD-API and will be completed with the corresponding editorial review.
RegulatedAnx. IIIRef. III/376
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraen-1-ol; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] acetate; [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate
- CAS
- 11103-57-4, 127-47-9, 68-26-8, 79-81-2
- Reference
- III/376
- Max conc.
- (a) 0,05 % Retinol Equivalent (RE) (b) 0,3 % RE
Last CosIng update
4 April 2024
Detailed EU regulation
%
Maximum permitted concentration
(a) 0,05 % Retinol Equivalent (RE) (b) 0,3 % RE
§
Regulatory framework
Regulation (EC) No 1223/2009 — Annex III, ref. 376
Last update reflected in the database: 4 April 2024
!
Conditions of use
From 1 November 2025 cosmetic products containing that substance and not complying with the conditions shall not be placed on the Union market. From 1 May 2027 cosmetic products containing that substance and not complying with the conditions shall not be made available on the Union market.
⚠
Labelling warnings
For any cosmetic product containing Retinol, Retinyl Acetate or Retinyl Palmitate the following, labelling is obligatory: ‘Contains Vitamin A. Consider your daily intake before use’.
Recent analyses mentioning this substance
No analyses published yet for this substance. This section will be filled with regulatory blog articles as they are published.
Data source: Official CosIng from the European Commission, updated on 4 April 2024. Learn more →